Eagle Rock Investment Company’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Eagle Rock Investment Company's GILD Position: Q2 2026 in Review
Eagle Rock Investment Company increased its Gilead Sciences (GILD) stake by 0.04% in Q2 2026, buying an estimated $527 and bringing the position to 9,288 shares worth $1.17M. The position accounts for 0.15% of the portfolio, ranked #89.
Eagle Rock Investment Company first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.29M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Eagle Rock Investment Company held 9,288 shares of Gilead Sciences worth $1.17M as of Q2 2026.
- Eagle Rock Investment Company bought 4 Gilead Sciences shares in Q2 2026, an estimated $527.
- Gilead Sciences made up 0.15% of Eagle Rock Investment Company's portfolio in Q2 2026, its #89 holding.
- Eagle Rock Investment Company first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
- Eagle Rock Investment Company's Gilead Sciences position peaked at $1.29M in Q1 2026.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.